INCB 018424-13C,15N2

INCB 018424-13C,15N2 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

As labelled racemic analogue of Ruxolitinib (R702000), rac-Ruxolitinib-13C,15N2 is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.

INCB 018424-13C,15N2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

INCB 018424-13C,15N2 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Guangzhou PI PI Biotech Inc	+86-020-81716320 +86-13602409664	Sales@pipitech.com	China	3635	55
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15421	60
Hubei Yangxin Medical Technology Co., Ltd.	15374522761	3003392093@qq.com	China	7851	55
PI & PI BIOTECH INC.	020-81716320 17788709170	Sales@pipitech.com	China	2649	58
Nanjing Shizhou Biology Technology Co.,Ltd	17301488900	judy.xia@synzest.com	China	13698	58

---

• INCB 018424-13C,15N2
• rac-Ruxolitinib-13C,15N2
• β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazole-1-propanenitrile
• INCB 018424-d8
• rac-Ruxolitinib-d8
• 1794791-38-0